|
FY2026
12 months to Jan 31, 2026
|
FY2025
12 months to Jan 31, 2025
|
FY2024
12 months to Jan 31, 2024
|
FY2024
12 months to Apr 30, 2024
|
FY2022
12 months to Jan 31, 2022
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of goods sold | |||||
| Gross profit | |||||
| Operating expenses | |||||
| Goodwill impairment | |||||
| Gain on sale-leaseback | |||||
| Lease impairments | |||||
| Operating loss | |||||
| Impairment of equity method investment | |||||
| Other (expense) income, net | |||||
| Interest expense | |||||
| Income before taxes | |||||
| Loss before income tax expense (benefit) | |||||
| Income tax expense (benefit) | |||||
| Net loss | |||||
| Net loss per common share: | |||||
| Basic | |||||
| Diluted | |||||
| Weighted average common shares outstanding: | |||||
| Basic | |||||
| Diluted |
Loading...
